Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Genetic characterization of HIV type 1 Nef-induced vesicle secretion.

Ali SA, Huang MB, Campbell PE, Roth WW, Campbell T, Khan M, Newman G, Villinger F, Powell MD, Bond VC.

AIDS Res Hum Retroviruses. 2010 Feb;26(2):173-92. doi: 10.1089/aid.2009.0068.

2.

Validation of a novel secretion modification region (SMR) of HIV-1 Nef using cohort sequence analysis and molecular modeling.

Campbell PE, Isayev O, Ali SA, Roth WW, Huang MB, Powell MD, Leszczynski J, Bond VC.

J Mol Model. 2012 Oct;18(10):4603-13. doi: 10.1007/s00894-012-1452-x.

3.

Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release.

Shelton MN, Huang MB, Ali SA, Powell MD, Bond VC.

J Virol. 2012 Jan;86(1):406-19. doi: 10.1128/JVI.05720-11.

4.

Specific and distinct determinants mediate membrane binding and lipid raft incorporation of HIV-1(SF2) Nef.

Giese SI, Woerz I, Homann S, Tibroni N, Geyer M, Fackler OT.

Virology. 2006 Nov 25;355(2):175-91.

6.

HIV-1 Nef protein is secreted into vesicles that can fuse with target cells and virions.

Campbell TD, Khan M, Huang MB, Bond VC, Powell MD.

Ethn Dis. 2008 Spring;18(2 Suppl 2):S2-14-9.

8.

Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.

Shahid A, Olvera A, Anmole G, Kuang XT, Cotton LA, Plana M, Brander C, Brockman MA, Brumme ZL.

J Virol. 2015 Nov;89(22):11557-71. doi: 10.1128/JVI.01955-15.

9.

Modulation of cellular protein trafficking by human immunodeficiency virus type 1 Nef: role of the acidic residue in the ExxxLL motif.

Coleman SH, Madrid R, Van Damme N, Mitchell RS, Bouchet J, Servant C, Pillai S, Benichou S, Guatelli JC.

J Virol. 2006 Feb;80(4):1837-49.

10.
11.

CHMP7, a novel ESCRT-III-related protein, associates with CHMP4b and functions in the endosomal sorting pathway.

Horii M, Shibata H, Kobayashi R, Katoh K, Yorikawa C, Yasuda J, Maki M.

Biochem J. 2006 Nov 15;400(1):23-32.

12.
14.

An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I.

Dikeakos JD, Thomas L, Kwon G, Elferich J, Shinde U, Thomas G.

Mol Biol Cell. 2012 Jun;23(11):2184-97. doi: 10.1091/mbc.E11-11-0928.

15.

The Nef-like effect of murine leukemia virus glycosylated gag on HIV-1 infectivity is mediated by its cytoplasmic domain and depends on the AP-2 adaptor complex.

Usami Y, Popov S, Göttlinger HG.

J Virol. 2014 Mar;88(6):3443-54. doi: 10.1128/JVI.01933-13. Erratum in: J Virol. 2014 May;88(10):5900.

16.

Overlapping effector interfaces define the multiple functions of the HIV-1 Nef polyproline helix.

Kuo LS, Baugh LL, Denial SJ, Watkins RL, Liu M, Garcia JV, Foster JL.

Retrovirology. 2012 May 31;9:47. doi: 10.1186/1742-4690-9-47.

17.

Microglia-derived HIV Nef+ exosome impairment of the blood-brain barrier is treatable by nanomedicine-based delivery of Nef peptides.

Raymond AD, Diaz P, Chevelon S, Agudelo M, Yndart-Arias A, Ding H, Kaushik A, Jayant RD, Nikkhah-Moshaie R, Roy U, Pilakka-Kanthikeel S, Nair MP.

J Neurovirol. 2016 Apr;22(2):129-39. doi: 10.1007/s13365-015-0397-0.

PMID:
26631079
18.

Fusogenic activity of amino-terminal region of HIV type 1 Nef protein.

Curtain CC, Separovic F, Rivett D, Kirkpatrick A, Waring AJ, Gordon LM, Azad AA.

AIDS Res Hum Retroviruses. 1994 Oct;10(10):1231-40.

PMID:
7848681
19.

Down-regulation of CTLA-4 by HIV-1 Nef protein.

El-Far M, Isabelle C, Chomont N, Bourbonnière M, Fonseca S, Ancuta P, Peretz Y, Chouikh Y, Halwani R, Schwartz O, Madrenas J, Freeman GJ, Routy JP, Haddad EK, Sékaly RP.

PLoS One. 2013;8(1):e54295. doi: 10.1371/journal.pone.0054295.

Items per page

Supplemental Content

Support Center